Contineum Therapeutics (CTNM) Shares Outstanding (Entity) (2023 - 2026)
Contineum Therapeutics' Shares Outstanding (Entity) came in at 38.39 million for Q3 2026, up 31.6% from 29.18 million a year earlier and up 2.5% from the prior quarter.
Powered by 
Analysis
Contineum Therapeutics (CTNM) Shares Outstanding (Entity) (2023 - 2026) Analysis & Trends
For FY2025, Contineum Therapeutics' Shares Outstanding (Entity) was 37.32 million, up 44.3% from FY2024.
- Going back by year, Shares Outstanding (Entity) was 25.85 million in FY2024 (+183.7%) and 9.11 million in FY2023.
- The Q3 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2023.
- Year-over-year, Shares Outstanding (Entity) has increased for ten consecutive quarters, with growth averaging 68.3% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 0.0% in Q1 2024 to 183.8% in Q1 2025.
- Business Quant data shows CTNM's Shares Outstanding (Entity) at 37.47 million (Q2 2026), 37.34 million (Q1 2026) and 37.32 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 940.75 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 540.90 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Contineum Therapeutics | 405.40 Mn | -584.86 Mn | - | 38.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 38.39 Mn |
| Jun 30, 2026 | 37.47 Mn |
| Mar 31, 2026 | 37.34 Mn |
| Dec 31, 2025 | 37.32 Mn |
| Sep 30, 2025 | 29.18 Mn |
| Jun 30, 2025 | 25.90 Mn |
| Mar 31, 2025 | 25.87 Mn |
| Dec 31, 2024 | 25.85 Mn |
| Sep 30, 2024 | 25.73 Mn |
| Jun 30, 2024 | 25.72 Mn |
| Mar 31, 2024 | 9.11 Mn |
| Dec 31, 2023 | 9.11 Mn |
| Sep 30, 2023 | 9.11 Mn |
| Jun 30, 2023 | 9.11 Mn |
| Mar 31, 2023 | 9.11 Mn |
API Access
Contineum Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CTNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "CTNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CTNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();